Navigation Links
AACR-NCI-EORTC to hold molecular targets meeting in San Francisco
Date:11/9/2011

SAN FRANCISCO -- Progress in oncology drug development will take center stage Nov. 12-16, 2011, as thousands of scientists and industry experts convene at the Moscone Center West in San Francisco for the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics.

"During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer," said program co-chairperson Kenneth C. Anderson, M.D., Kraft Family professor of medicine and program director and chief of the division of hematologic neoplasia at Dana-Farber Cancer Institute and Harvard Medical School. "The level of excitement surrounding targeted therapy and the high caliber of the science to be presented fuel the power of this meeting to attract the world's leaders in cancer therapeutics."

Anderson, who is also editor in chief of Clinical Cancer Research, a journal of the American Association for Cancer Research, will host a press conference on new research in breast cancer at 7:00 a.m. PT on Sunday, Nov. 12.

The press conference will feature the following research:

HDAC Inhibitor May Overcome Resistance to Common Breast Cancer Drug

Benefit of Novel Drug in Breast Cancer Seen in Blood Within Weeks

Signaling Pathway Linked to Inflammatory Breast Cancer May Drive Disease Metastasis

On Nov. 12 at 11:00 a.m. PT, program co-chairperson James H. Doroshow, M.D., FACP, deputy director for clinical and translational research at the National Cancer Institute, will host a press conference on progress in angiogenesis.

The press conference will feature the following research:

Researchers Develop More Effective Way to Discover and Test Potential Cancer Drugs

Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy

Combination Therapy Shows Potent Tumor Growth Inhibition in Preclinical Studies

Both press conferences will take place in Room 2004 of the Moscone Center. Reporters who cannot attend in person can call in using the following information:

U.S./Canada: 888-647-7462

International: 201-604-0169

In addition to the press conference, the program chairpersons have designated the following research projects as newsworthy:

Antifolates Show Promise Against NSCLC Subtype

New Approaches May Prevent Certain Side Effects in BRAF Mutation-Positive Melanoma

Panel of Melanoma Mutations Opens Door to New Treatment Possibilities


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Molecular pathways linked to sex, age affect outcomes in lung cancer
2. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
3. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
4. The Association for Molecular Pathology celebrates ruling in DNA patent case
5. USC researchers discover new molecular subtype of brain cancer
6. Molecular discovery points to new therapies for brain tumors
7. Molecular marker could help spot pancreatic cancer early
8. News from Molecular Medicine
9. Scientists discover the molecular heart of collective behavior
10. Salt Lake City proclaims Molecular Imaging Days during SNMs Annual Meeting in June
11. Acupunctures molecular effects pinned down
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... WA (PRWEB) , ... May 05, 2016 , ... ... ranking for overall select performance in the industry’s gold standard KLAS ... The Epic Consulting report assessed organizations that specialize in consulting services for ...
(Date:5/5/2016)... ... May 05, 2016 , ... The U.S. Food and Drug ... manufacturers to submit their products through an arduous federal approval process. The rules, ... entered the market since February 15, 2007. That would essentially ban 99 percent ...
(Date:5/5/2016)... , ... May 05, 2016 , ... TLC Laser Eye ... Diego, California. The laser eye center will now be called “Gordon Schanzlin New Vision ... staff will remain at the full-service facility to ensure that patients continue to receive ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... ultraviolet light A (UV-A) for photosynthesis, researchers Juntian Xu and Kunshan Gao tested ... seaweeds. The pair observed that when photosynthetically active radiation (i.e. the white light ...
(Date:5/5/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... addition to its family of Partner Firms. Headquartered in Mount Pleasant, South Carolina, ... and health care consumerism specialists. , “Partnering with UBA will enable our firm ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... May 5, 2016 Endo International plc (NASDAQ: ... Douglas S. Ingram , former president of Allergan, Inc. ... B. Sisitsky , managing partner of TPG Capital, to its ... "Endo recently embarked on a ... and expand the Board,s capabilities. Doug and Todd are experienced ...
(Date:5/5/2016)... 2016  Diagnostic imaging has been on the ... that these tests cause health care costs to spike. However, ... well as the adoption of new guidelines are ... that help health care providers cut costs, while helping patients ... a renowned authorized reseller of the medical industry,s ...
(Date:5/5/2016)... , May 5, 2016 /PRNewswire/ ... announced the addition of the  "Europe ... - 2016"  report to their offering.  ... ) , ,The latest research ... Highlights - 2016, provides comprehensive insights ...
Breaking Medicine Technology: